TickerFactsScreenerDevelopers

NovoCure Ltd (NVCR) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $2.20M2014: $849.0K2015: $4.67M2016: $5.67M2017: $7.37M2018: $6.71M2019: $10.48M2020: $14.97M2021: $24.17M2022: $21.36M2023: $27.09M2024: $42.85M2025: $26.65M$26.65M
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$26.65M-37.8%
2024$42.85M+58.2%
2023$27.09M+26.9%
2022$21.36M-11.6%
2021$24.17M+61.5%
2020$14.97M+42.8%
2019$10.48M+56.2%
2018$6.71M-8.9%
2017$7.37M+29.8%
2016$5.67M+21.6%
2015$4.67M+449.7%
2014$849.0K-61.4%
2013$2.20M—